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Abstract
Mutations in the KAL-1 gene localized at Xp22.3 have been shown to be responsible for the X-linked Kallmann
syndrome (KS), a disorder characterized by the association of hypogonadotropic hypogonadism and anosmia. In
this paper, we describe the investigation of two families with X-linked KS, in which similar interstitial deletions
spanning exons 5 to 10 of the KAL-1 gene were identified. The presence of interspersed repetitive DNA sequences
within the KAL-1 gene might have predisposed to this type of mutation.
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Introduction
Kallmann syndrome (KS) is a disorder defined by the
association of hypogonadotropic hypogonadism with
anosmia or hyposmia (Kallmann et al., 1944) that is due to
a neuronal migration defect involving both the gonadotro-
pin-releasing hormone (GnRH) and the olfactory-
producing neurons (Schwanzel-Fukuda et al., 1989). Al-
though the majority of KS cases are sporadic, segregation
analysis in familial cases revealed X-linked, as well as
autosomal recessive and autosomal dominant modes of
transmission, indicating genetic heterogeneity (Hermanus-
sen and Sippell, 1985; Chaussain et al., 1988; Walds-
treicher et al., 1996).
The KAL-1 gene responsible for the X-linked form of
KS (MIM 308700) was mapped to Xp22.3 by linkage anal-
ysis and deletion studies (Ballabio et al., 1989; Petit et al.,
1990) and was subsequently isolated by different positional
cloning strategies (Franco et al., 1991; Legouis et al.,
1991). This gene consists of 14 exons spanning approxi-
mately 210 kb (Del Castillo et al., 1992) and encodes a pro-
tein, anosmin-1, that contains four fibronectin type III
repeats and a putative protease inhibitor domain, structural
features found in several cell and substrate adhesion mole-
cules (Franco et al., 1991; Legouis et al., 1991). This raises
the possibility that anosmin-1 could function in the migra-
tion of GnRH-secreting neurons and olfactory axons, dur-
ing embryonic development (Franco et al., 1991; Legouis
et al., 1991; Rugarli et al., 1996).
In addition to hypogonadism and anosmia, a variety
of other defects occur in patients with X-linked KS. They
include neurological deficits such as bimanual synkinesis
(Kallmann et al., 1944; Sunohara et al., 1986), cerebellar
dysfunction, nystagmus (Sunohara et al., 1986; Schwan-
khaus et al., 1989), mental retardation (Kallmann et al.,
1944; Wegenke et al., 1975), hearing loss (White et al.,
1983), and somatic defects, such as unilateral renal
agenesis, pes cavus and high-arched palate (White et al.,
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1983; Schwankhaus et al., 1989; Zenteno et al., 1999).
Some of these symptoms (e.g. synkinesis and renal
agenesis) are more frequently observed in patients with
X-linked KS, indicating that these features represent
pleiotropic effects of mutations in the KAL-1 gene
(Hardelin et al., 1993) and suggesting a more generalized
role of this gene during development, involving the nervous
system and non-neuronal tissues (Hardelin et al.,
1992,1993).
In this paper, we report two unrelated Brazilian fami-
lies with X-linked KS and similar interstitial deletions
spanning exons 5 to 10 of the KAL-1 gene.
Subjects and Methods
Patient reports
We studied two unrelated families with KS-affected
males. In family 1 (Figure 1A), from Arapiraca, state of
Alagoas, northeastern Brazil, five males were clinically
evaluated (II-6, III-4, III-7, III-12, and IV-6), and in family
2 (Figure 1B), from Campinas, state of São Paulo, south-
eastern Brazil, two affected brothers (II-4 and II-6) were
examined. In family 1, X-linked inheritance of KS was as-
sumed, based on the presence of asymptomatic female car-
riers, the presence of at least two affected males in the
maternal family or among male siblings, the absence of af-
fected females and the absence of male-to-male transmis-
sion. In family 2, X-linked inheritance of KS was suspected
because one of the affected patients had a renal abnormal-
ity.
Laboratory testing was performed in all patients, re-
vealing low levels of testosterone, FSH (follicle-
stimulating hormone) and LH (luteinizing hormone), con-
sistent with hypogonadism. Formal olfactory testing was
not performed, but anosmia was detected in the individuals
II-6, III-4 (Family 1) and II-4 (Family 2) by direct inquiry.
Clinical evaluation details of all patients are given in Table
1. The protocol was approved by the Ethics Committee of
the State University of Campinas (UNICAMP) School of
Medicine. Informed consent was obtained from all subjects
included in this study.
Molecular analysis of the KAL-1 gene
Genomic DNA of individuals II-11, III-4 and III-17
(Family 1), I-2, II-4 and II-6 (Family 2) was extracted from
peripheral leukocytes, using the phenol/chloroform
method. The 14 coding exons of the KAL-1 gene were am-
plified by PCR from DNA of the affected males, patients
III-4 (Family 1), II-4 and II-6 (Family 2). The sequences of
primers and the size of the amplified products were as pre-
viously described by Hardelin et al. (1993). PCR amplifica-
tions were performed in 50 µL reaction mixes containing
200-500 ng of genomic DNA, 0.2mM dNTPs, 1.5 mM of
MgCl2, 0.6 pmol of each of the primers, 1x PCR buffer, and
1 U Taq polymerase. After a first denaturation step (10 min,
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Figure 1 - Heredograms of (a) family 1 and (b) family 2 with X-linked
KS. Affected males. Arrows indicate patients clinically examined in this
study.



























III-7* 6 y ? Yes Yes Yes No High-arched palate Not performed
III-12* 4 mo ? Yes Yes ? No Not performed
IV-6* 4 mo ? Yes Yes ? No Epicanthal folds Bi-
lateral ptosis of eye-
lids Asymmetric ears
Not performed
II-4# 35 y Yes Yes Yes No No Gynecomastia Not performed
II-6# 28 y No Yes Yes No Horseshoe kidney
on right side
Mental retardation Not performed
*patients from family 1; # patients from family 2. y = year. mo = months. adetected by direct inquiry. bdetermined by abdominal ultrasonography. ? fea-
tures not evaluated due to patient age.
95 °C), 30 PCR amplification cycles of 1 min at 95 °C,
1 min at 57 °C (except for exon 1, 60 °C), and 2 min at
72 °C were carried out, followed by a final extension of
10 min at 72 °C. The PCR products were electrophoresed
on 1.5% agarose gel, stained with ethidium bromide and
photographed. If no amplification product of KAL-1 exons
was detected, PCR was repeated with the addition of prim-
ers SRY1 and SRY4 for the SRY gene (Assumpção et al.,
2002) as internal positive control.
Comparative duplex PCR for carrier female status de-
termination was performed, following the procedure de-
scribed by Nagata et al. (2000), in subjects II-11 and III-17
(Family 1) and I-2 (Family 2), mothers of affected males.
The reactions included primers for exon 20 of the
autosomal NPC1 gene as internal standard to quantify the
dosage of KAL-1 exon 7 PCR products. The amplified
products were analyzed by electrophoresis on 2.6% agarose
gel stained with ethidium bromide, and the gel image was
captured with a Kodak Digital Science DC120 camera. The
intensity of each band was measured using 1D IMAGE
ANALYSIS software, and the gene dosage was evaluated
by the KAL-1/NPC1 ratio. Samples from normal males
(n = 10) and females (n = 10) were also run as controls. The
expected values were 0.0, 0.5, and 1.0 for affected males,
carrier females and normal males, and normal females, re-
spectively.
Results
The genomic DNA from patients III-4 (Family 1),
II-4 and II-6 (Family 2) did not yield PCR products from
exon 5 to exon 10, while the remaining exons were ampli-
fied. These findings indicate the presence of an interstitial
deletion encompassing exons 5-10 in the KAL-1 gene of
these patients (Figure 2).
By duplex PCR, the status of obligatory carrier fe-
males was confirmed in subjects II-11 and III-17 (Family 1)
and I-2 (Family 2). In these females, the KAL-1/NPC1 ra-
tios were 0.53, 0.54 and 0.47, respectively, indicating the
presence of only one normal KAL-1 allele. In the control
subjects, the KAL-1/NPC1 ratios were next to 0.5 for males
and 1.0 for females (Figure 3).
Discussion
We describe here two interstitial deletions of the
KAL-1 gene encompassing exons 5-10 in two unrelated and
geographically distant Brazilian families. Although molec-
ular analysis by PCR was performed in only one patient
from Family 1, the causative role of the KAL-1 gene for KS
in this family was confirmed by the demonstration of the
carrier status of the mothers of patients III-12 and IV-6. Ad-
ditional symptoms found in the five clinically examined af-
fected males of this family included bimanual synkinesis
(3/5), renal agenesis (1/5), high-arched palate (3/5), and
dysmorphic facial features (1/5). In Family 2, molecular in-
vestigation of the KAL-1 gene was performed in both pa-
tients, and the carrier status of their mother was also dem-
onstrated. One of these patients had mental retardation and
a horseshoe right kidney in association with KS.
Nagata et al. (2000) described two brothers with
X-linked KS due to a deletion of exons 5-10 of the KAL-1
gene, but neither mental retardation nor bimanual
synkinesis were reported to be present. In fact, mental retar-
dation is rarely observed in patients with isolated KS, but
has been described in patients affected by associations of
several diseases linked to Xp22.3, as contiguous gene syn-
dromes (Meindl et al., 1993; Weissortel et al., 1998).
Bimanual synkinesis is one of the most frequent findings
and is considered a marker for X-linked KS (Krams et al.,
1999; Quinton et al., 2001), with an estimated prevalence
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Figure 2 - PCR amplification of exons 4 (334 bp), 5 (267 bp), 10 (293 bp),
and 11 (272 bp) of the KAL-1 gene in two patients affected by X-linked
KS. Lanes 1-4 correspond, respectively, to a normal 46,XY male, patient
III-4 (Family 1), patient II-6 (Family 2), and a negative control with omis-
sion of the genomic DNA in the PCR. Lane M: molecular weight marker.
Exons 4 and 11 (a) may be amplified in the three males (lanes 1-3),
whereas exons 5 and 10 are amplified only in the control male (lane 1). For
exons 5 and 10 (b), a product of the SRY gene (internal positive control,
380 bp) can also be visualized.
Figure 3 - Comparative duplex PCR for identification of carrier females.
Lanes: 1 - control female; 2 - control male; 3-5 - individuals from family 1,
respectively, III-4 (affected male), II-11 and III-17 (mothers of patients
III-12 and IV-6); and 6 - individual I-2 from family 2 (mother of patients
II-4 and II-6). M - molecular weight marker. Values for the KAL-1/NPCI
ratio are given below each lane.
of 85% among X-KS patients (MacColl et al., 2002). How-
ever, in a recent report on a family with a mutation in the
FRGR1 gene (KAL-2), mapped to 8p, bimanual synkinesis
was observed, suggesting that this feature should not be
considered specific to the X-linked form (Dodé et al.,
2003).
Several small deletions, point mutations and a few
single-exon deletions have been identified in the KAL-1
gene in patients with KS (Hardelin et al., 1992; Parenti et
al., 1995; Georgopoulus et al., 1997; Quinton et al., 1996;
Söderlund et al., 2002). Large deletions involving more
than one exon of KAL-1 have been reported for exons 13-14
(Bick et al. (1992), 3 to 5 (Maya-Nunez et al., 1998), 5 to 10
(Nagata et al., 2000), and 3 to 13 (Massin et al., 2003). Al-
though the breakpoints were not determined in most cases,
it is possible that intronic regions flanking these deletions
contain repeated elements that might promote nonallelic re-
combination. We used the RepeatMasker software (http://
ftp.genome.washington.edu/cgi-bin/RepeatMasker", ac-
cessed 9/16/2003) for repeat identification in the intronic
sequences between exons 4-5 and 10-11 of KAL-1. Ele-
ments of a FLAM_A repeat of the Alu family were found in
both introns on opposite strands (Figure 4a). Although no
similarity was found between these two elements using
BLAST (, accessed 10/7/2003), a significant similarity
score was detected for a short sequence of 51 nucleotides
when the whole intronic sequences were compared (Figure
4b). This short sequence is contained in the FLAM_A re-
peat in intron 10 and is adjacent to the FLAM_A repeat in
intron 4. These analyses failed to detect other repeats with
remarkable sequence identity that could mediate illegiti-
mate recombination events.
In the deletion of exons 13-14 described by Bick et al.
(1992), sequencing of the junction fragments revealed a 6
bp homology motif (CAAATT) at the deletion breakpoints.
These short stretches of sequence homology have been sug-
gested to facilitate end-joining in recombination events in
several regions of the genome (Krawczak and Cooper,
1991; Woods-Samuels et al., 1991). It is noteworthy that
copies of this 6bp motif are present in the intronic se-
quences flanking the 5-10 deletion (Figure 4a). Thus, at
least two different molecular mechanisms may be responsi-
ble for the observed intragenic deletion. Together with the
similar deletion previously described by Nagata et al.
(2000), our data suggest that a recurrent mechanism could
predispose to this specific large exon-type deletion.
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